Study search
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Dulaglutide research reference →
1,317 records · showing 25 · open this search in PubMed
- PubMedCardiovascular outcomes with tirzepatide versus semaglutide in type 2 diabetes.Journal of diabetes and metabolic disorders · 2026 Dec
- PubMedReviewResearch Support, Non-U.S. Gov'tGLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.Annals of medicine · 2026 Dec
- PubMedCalculating cost per event avoided using a composite number needed to treat.Journal of medical economics · 2026 Dec
- PubMedCase ReportsDulaglutide-associated interstitial granulomatous dermatitis: A case report.JAAD case reports · 2026 Nov
- PubMedClinical Trial, Phase IIRandomized Controlled TrialDulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).Diabetologia · 2026 Nov
- PubMedRandomized Controlled TrialClinical Trial, Phase IIRetatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.Diabetes, obesity & metabolism · 2026 Nov
- PubMedRisk of Dementia after initiation of GLP-1 RA versus long-acting insulin in patients with type 2 Diabetes mellitus.The journal of prevention of Alzheimer's disease · 2026 Nov
- PubMedImpact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.Digestive diseases and sciences · 2026 Nov
- PubMedSystematic ReviewSkeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review.Archives of osteoporosis · 2026 Oct 23
- PubMedReviewGLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.European journal of clinical pharmacology · 2026 Oct 23
- PubMedOral Versus Injectable Incretin-Based Anti-Obesity Therapies: An Integrated Computational and Evidence-Based Comparison of Orforglipron, Semaglutide, and Tirzepatide.Omics : a journal of integrative biology · 2026 Oct 20
- PubMedRandomized Controlled TrialClinical Trial, Phase IIRetatrutide and lipid and metabolite profiles in participants with obesity with or without type 2 diabetes.The Journal of clinical endocrinology and metabolism · 2026 Oct 16
- PubMedOutcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis.European journal of preventive cardiology · 2026 Oct 15
- PubMedReviewGLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies.Biological psychiatry · 2026 Oct 15
- PubMedSystematic ReviewReviewEffects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review.Acta neuropsychiatrica · 2026 Oct 14
- PubMedAudiovestibular adverse event reporting profiles of GLP-1 receptor agonists: A case-case pharmacovigilance study using FDA AEMS data.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026 Oct 13
- PubMedReviewThe therapeutic potential of GLP-1 receptor agonists in central nervous system diseases: immune cell modulation and neuroinflammation.Expert review of clinical immunology · 2026 Oct 13
- PubMedIn brief: A cardiovascular indication for tirzepatide (Mounjaro).The Medical letter on drugs and therapeutics · 2026 Oct 12
- PubMedGLP-1 Receptor Agonists Are Associated With Lower Early Revision Risk Compared to Bariatric Surgery Following Total Hip Arthroplasty: A Retrospective Cohort Study.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2026 Oct 7
- PubMedNisotirostide (LY3457263), a novel NPY2 receptor agonist for type 2 diabetes and obesity: From discovery to clinical proof of concept.Molecular metabolism · 2026 Oct 3
- PubMedGlucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 Oct 3
- PubMedTirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues.BMJ open · 2026 Oct 1
- PubMedGlucagon-like peptide-1 receptor agonists in psoriasis management.Clinics in dermatology · 2026 Oct 1
- PubMedCase ReportsSustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.JCEM case reports · 2026 Oct
- PubMedSystematic ReviewMeta-AnalysisGLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.Drugs · 2026 Oct
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.